Clinical Trials at Presbyterian/St. Luke’s Medical Center
A clinical trial is a research study to evaluate new drugs, treatments, or medical procedures to determine their effectiveness and safety. Research studies provide valuable data about new and emerging cancer therapies, how they should be used, and which patients may benefit the most.
Presbyterian/St. Luke’s is pleased to offer patients access to the latest treatments in clinical trials:
Sarah Cannon Research Institute
Through its partnership with Sarah Cannon Research Institute, the research arm of Sarah Cannon, Presbyterian/St. Luke’s offers its patients access to innovative clinical trials, including many first-in-man studies.
A world leader in cancer research, Sarah Cannon has been a clinical trial leader in nearly two-thirds of approved cancer therapies over the past 10 years. Sarah Cannon Cancer Institute at Presbyterian/St. Luke’s brings together the most innovative medical minds and resources to deliver cutting-edge therapies and compassionate care.
Together with Sarah Cannon, the global cancer institute of HCA, Presbyterian/St. Luke's is committed to providing innovative clinical trials to those facing cancer in Denver.
Colorado Blood Cancer Institute
Patients also have access to hematological (blood) cancer clinical trials through Colorado Blood Cancer Institute (CBCI). Learn more here: http://bloodcancerinstitute.com/clinical-trials/
Rocky Mountain Cancer Center
Through the US Oncology Research program, Rocky Mountain Cancer Center provides access to more than one hundred clinical trials for the latest treatments for many types of cancer.
Ask your oncology care team at Presbyterian/St. Luke’s if there is a current trial that is right for you in your cancer journey.